ADMA Biologics Ownership | Who Owns ADMA Biologics?
ADMA Biologics Ownership Summary
ADMA Biologics is owned by 85.93% institutional investors, 2.59% insiders, and 11.49% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.26% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.98% of its assets in ADMA Biologics shares.
ADMA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | ADMA Biologics | 85.93% | 2.59% | 11.49% |
Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 38.15M | 16.26% | $654.27M |
Blackrock | 18.64M | 8.15% | $208.45M |
Vanguard group | 18.20M | 7.76% | $312.11M |
State street | 14.87M | 6.34% | $255.03M |
Invesco | 11.30M | 4.82% | $193.73M |
Geode capital management | 5.43M | 2.32% | $93.19M |
Awm investment company | 5.10M | 2.23% | $56.99M |
Morgan stanley | 4.60M | 2.01% | $51.41M |
Dimensional fund advisors lp | 4.67M | 1.99% | $80.07M |
Nuveen asset management | 4.55M | 1.94% | $78.07M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Stonepine capital management | 1.24M | 17.18% | $21.28M |
Awm investment company | 5.10M | 7.70% | $56.99M |
Ophir asset management pty | 1.34M | 3.43% | $23.01M |
Oberweis asset management inc/ | 3.34M | 2.70% | $57.32M |
New millennium group | 214.31K | 2.15% | $3.68M |
First turn management | 684.23K | 2.10% | $11.73M |
Mesirow institutional investment management | 782.45K | 1.03% | $13.42M |
Perpetual | 3.63M | 0.73% | $62.30M |
Lisanti capital growth | 175.47K | 0.72% | $3.01M |
Clarivest asset management | 575.25K | 0.66% | $6.43M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Perpetual | 3.63M | 0.73% | 3.63M |
Allspring global investments | 2.84M | 0.08% | 2.61M |
State street | 14.87M | 0.01% | 1.87M |
Fmr | 3.20M | 0.00% | 1.25M |
Raymond james financial | 1.11M | 0.01% | 1.11M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Assenagon asset management | 591.68K | 0.02% | -2.88M |
D. e. shaw | 3.07M | 0.04% | -2.20M |
Bank of montreal /can/ | 26.56K | 0.00% | -2.06M |
Nuveen asset management | 4.55M | 0.02% | -2.03M |
Velan capital investment management lp | - | - | -1.53M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Perpetual | 3.63M | 0.73% | 3.63M | $62.30M |
Raymond james financial | 1.11M | 0.01% | 1.11M | $19.08M |
Tang capital management | 550.00K | 0.62% | 550.00K | $9.43M |
Royce & associates lp | 420.57K | 0.07% | 420.57K | $7.21M |
Simplify asset management | 385.19K | 0.33% | 385.19K | $6.61M |
Sold Out
Holder | Change |
---|---|
Mendota financial group | -4.00 |
Global financial private client | -24.00 |
Aquatic capital management | -27.00 |
Stephens consulting | -60.00 |
Ancora advisors | -100.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 357 | 8.51% | 204,309,752 | 0.18% | 85 | 1.14% | 192 | -4.00% | 113 | 9.71% |
Dec 31, 2024 | 321 | 3.55% | 200,305,365 | -3.74% | 85 | 1.09% | 196 | 1.55% | 99 | 2.06% |
Sep 30, 2024 | 309 | 20.23% | 208,056,497 | 15.00% | 88 | 1.42% | 193 | 29.53% | 96 | 18.52% |
Jun 30, 2024 | 255 | 17.51% | 180,834,881 | 3.64% | 79 | 1.33% | 149 | 7.97% | 80 | 53.85% |
Mar 31, 2024 | 217 | 16.67% | 174,477,070 | 3.15% | 77 | 1.37% | 138 | 50.00% | 52 | -10.34% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Small-Cap ETF | 14.26M | 5.98% | 2.05K |
Vanguard Total Stock Mkt Idx Inv | 7.32M | 3.07% | 901.74K |
Vanguard US Total Market Shares ETF | 7.15M | 3.01% | 281.42K |
iShares Russell 2000 ETF | 5.46M | 2.29% | -103.74K |
Vanguard Institutional Extnd Mkt Idx Tr | 3.68M | 1.54% | 414.00 |
SPDR® S&P Biotech ETF | 3.23M | 1.35% | 79.58K |
Xtrackers MSCI World Swap ETF 1C | 2.97M | 1.24% | - |
CREF Stock R1 | 2.80M | 1.20% | -102.61K |
Vanguard Small Cap Index | 2.77M | 1.16% | 2.77M |
American Century Small Cap Growth Inv | 2.62M | 1.10% | 447.92K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 15, 2025 | Grossman Adam S | President and CEO | Sell | $279.90K |
Jul 15, 2025 | Grossman Adam S | President and CEO | Sell | $111.96K |
Jun 16, 2025 | Grossman Adam S | President and CEO | Sell | $312.15K |
Jun 16, 2025 | Grossman Adam S | President and CEO | Sell | $124.86K |
Jun 12, 2025 | ELMS STEVE | - | Sell | $2.02M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 2 |
2025 Q2 | - | 13 |
2025 Q1 | - | 2 |
2024 Q4 | - | 2 |
2024 Q3 | - | 6 |
ADMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools